查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790454

美國兒童糖尿病管理市場規模、佔有率和趨勢分析報告：按產品、技術、最終用途和細分市場預測，2025 年至 2033 年

U.S. Pediatric Diabetes Management Market Size, Share & Trends Analysis Report By Product (CGM, BGM, Insulin Pump, Insulin Pen), By Technology (Connected, Non-Connected), By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

市場規模和趨勢

預計 2024 年美國兒童糖尿病管理市場規模為 20.159 億美元，到 2033 年將達到 46.912 億美元，2025 年至 2033 年的複合年成長率為 9.9%。

市場成長受多種因素驅動，包括兒童和青少年糖尿病盛行率的上升、糖尿病管理設備的技術進步，以及人們對早期診斷和主動糖尿病管理重要性的認知不斷提高。此外，政府的支持和有利的監管舉措，包括旨在提高醫療保健可近性的舉措，也進一步推動了市場的成長。

美國兒童糖尿病的盛行率正在顯著上升，這必然導致對糖尿病管理解決方案的需求增加。此外，向主動預防性醫療保健的轉變，加上家長和醫療保健提供者認知的提高，正在推動早期診斷和早期療育，從而進一步擴大市場。先進醫療保健基礎設施的出現也推動了市場擴張，包括能夠處理複雜糖尿病病例的專門小兒科診所和醫院。政府機構和私人組織更加重視病患教育和支持計劃，這有助於改善疾病管理。例如，美國糖尿病協會 (ADA) 的「青少年力量計畫」是一個免費的、以社區和學校為基礎的項目，旨在幫助 5 至 12 歲的兒童降低 2 型糖尿病的風險並管理肥胖相關行為。該計劃透過適合年齡的互動內容教育青少年健康飲食和規律體能活動的重要性。

此外，技術創新在推動兒童糖尿病管理市場成長方面發揮關鍵作用。先進胰島素幫浦、連續血糖監測 (CGM) 系統和整合糖尿病管理平台的開發顯著改善了兒童糖尿病管理。此外，一些市場參與企業正致力於開發能夠自動化胰島素輸送的先進解決方案，進一步促進這些設備的普及。例如，2025 年 3 月，Tandem Diabetes Care 在美國推出了 Control-IQ+ 自動胰島素輸送技術，將其應用範圍擴大到 2 歲及以上的 1 型糖尿病患者和 2 型糖尿病成人患者。 Control-IQ+ 與 t:slim X2 胰島素幫浦和 Tandem Mobi 系統相容，具有擴展的體重和胰島素參數、長達 8 小時的延長Bolus以及新的臨時基礎體溫調節功能，可在運動、壓力和疾病期間改善血糖管理。它還包含用於自動校正劑量的Bolus，旨在改善血糖控制、易用性和針對不同使用者的個人化服務。這些技術的不斷發展，加上價格的不斷下降和易用性的不斷提高，預計將進一步推動市場擴張。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國兒童糖尿病管理市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國兒童糖尿病管理市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章美國兒童糖尿病管理市場：產品、估計與趨勢分析

  • 細分儀表板
  • 美國兒童糖尿病管理市場的產品差異分析
  • 2021-2033 年美國兒童糖尿病管理市場規模及趨勢分析（依產品）
  • 血糖值監測儀（BGM）
  • 連續血糖監測儀（CGM）
  • 胰島素幫浦
  • 胰島素筆
  • 胰島素注射器

第5章美國兒童糖尿病管理市場技術、預測與趨勢分析

  • 細分儀表板
  • 美國兒童糖尿病管理市場技術變革分析
  • 美國兒童糖尿病管理市場規模與趨勢分析（依技術分類）（2021-2033）
  • 連網型設備
  • 未連網型設備

第6章美國兒童糖尿病管理市場最終用途、預測與趨勢分析

  • 細分儀表板
  • 美國兒童糖尿病管理市場最終用途差異分析
  • 美國兒童糖尿病管理市場規模及趨勢分析（依最終用途），2021-2033 年
  • 醫院
    • 綜合醫院
    • 兒童醫院
  • 居家醫療
  • 小兒科診所

第7章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • Medtronic
    • Dexcom
    • Abbott
    • Tandem Diabetes Care
    • Insulet Corporation
    • Novo Nordisk
    • Sanofi
    • Eli Lilly and Company
    • Roche Diabetes Care
    • Ascensia Diabetes Care
Product Code: GVR-4-68040-653-2

Market Size & Trends:

The U.S. pediatric diabetes management market size was estimated at USD 2,015.9 million in 2024 and is projected to reach USD 4,691.2 million in 2033, registering a CAGR of 9.9% from 2025 to 2033. The market growth is driven by several factors, including the rising prevalence of diabetes among children and adolescents, technological advancements in diabetes management devices, and the growing awareness of early diagnosis and the importance of proactive diabetes management. Additionally, government support and advantageous regulatory policies, such as efforts to enhance access to care, further drive market growth.

The U.S. is witnessing a significant rise in diabetes prevalence among children, necessitating a rise in demand for diabetes management solutions. Furthermore, the shift towards proactive and preventative healthcare, coupled with increased awareness among parents and healthcare providers, has fueled early diagnosis and intervention, further expanding the market. The market's expansion is also influenced by the availability of advanced healthcare infrastructure, including specialized pediatric clinics and hospitals equipped to handle complex diabetes cases. The growing emphasis on patient education and support programs, facilitated by both government and private organizations, contributes to improved disease management. For instance, the Project Power for Youth by the American Diabetes Association (ADA), a free, community- and school-based program, is designed to help children aged 5 to 12 reduce their risk of type 2 diabetes and manage obesity-related behaviors. The program educates youth on the importance of healthy eating and regular physical activity through interactive, age-appropriate content.

Moreover, technological innovation plays a crucial role in driving the growth of the pediatric diabetes management market. The development of advanced insulin pumps, CGM systems, and integrated diabetes management platforms has significantly improved pediatric diabetes management. Moreover, several market players are focusing on developing advanced solutions that can automate insulin delivery, which can further drive the adoption of these devices. For instance, in March 2025, Tandem Diabetes Care launched Control-IQ+ automated insulin delivery technology in the U.S., extending its use to people with type 1 diabetes aged 2 years and older, and adults with type 2 diabetes. Compatible with the t:slim X2 insulin pump and Tandem Mobi System, Control-IQ+ features expanded weight and insulin parameters, enhanced extended bolus up to 8 hours, and new temporary basal rate adjustments to better manage glucose during exercise, stress, or illness. It includes AutoBolus for automatic correction doses and aims to improve glucose control, ease of use, and personalization for diverse users. The continuous evolution of these technologies, coupled with their increasing affordability and ease of use, is further expected to drive market expansion.

U.S. Pediatric Diabetes Management Market Report Segmentation

This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. pediatric diabetes management market report based on product, technology, and end use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Blood Glucose Monitors (BGM)
  • Continuous Glucose Monitors (CGM)
  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Connected Devices
  • Non-connected Devices
  • End Use Channels Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
    • General Hospitals
    • Children Hospitals
  • Homecare
  • Pediatric Clinics

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Technology Segment
    • 1.2.3. End use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Pediatric Diabetes Management Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of diabetes in children
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Rising awareness about diabetes management
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of diabetes management devices
  • 3.3. U.S. Pediatric Diabetes Management Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Pediatric Diabetes Management Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Pediatric Diabetes Management Market Product Movement Analysis
  • 4.3. U.S. Pediatric Diabetes Management Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Blood Glucose Monitors (BGM)
    • 4.4.1. Blood Glucose Monitors (BGM) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Continuous Glucose Monitors (CGM)
    • 4.5.1. Continuous Glucose Monitors (CGM) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Insulin Pumps
    • 4.6.1. Insulin pumps market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Insulin Pens
    • 4.7.1. Insulin pens market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Insulin Syringes
    • 4.8.1. Insulin syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Pediatric Diabetes Management Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Pediatric Diabetes Management Market Technology Movement Analysis
  • 5.3. U.S. Pediatric Diabetes Management Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Connected Devices
    • 5.4.1. Connected devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Non-connected Devices
    • 5.5.1. Non-connected devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Pediatric Diabetes Management Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Pediatric Diabetes Management Market End Use Movement Analysis
  • 6.3. U.S. Pediatric Diabetes Management Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. General Hospitals
      • 6.4.2.1. General hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Children Hospitals
      • 6.4.3.1. Children hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Homecare
    • 6.5.1. Homecare market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Pediatric Clinics
    • 6.6.1. Pediatric clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Medtronic
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Dexcom
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Abbott
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Tandem Diabetes Care
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Insulet Corporation
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Novo Nordisk
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Sanofi
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Eli Lilly and Company
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Roche Diabetes Care
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Ascensia Diabetes Care
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. pediatric diabetes management market by product, 2021 - 2033 (USD Million)
  • Table 4 U.S. pediatric diabetes management market by technology 2021 - 2033 (USD Million)
  • Table 5 U.S pediatric diabetes management market by End Use, 2021 - 2033 (USD Million)
  • Table 6 Participant's overview
  • Table 7 Financial performance
  • Table 8 Key companies undergoing expansions
  • Table 9 Key companies undergoing acquisitions
  • Table 10 Key companies undergoing collaborations
  • Table 11 Key companies launching new products
  • Table 12 Key companies undergoing partnerships
  • Table 13 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. pediatric diabetes management market: Market outlook
  • Fig. 5 U.S. pediatric diabetes management market: Segment outlook
  • Fig. 6 U.S. pediatric diabetes management market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. pediatric diabetes management market driver impact
  • Fig. 9 U.S. pediatric diabetes management market restraint impact
  • Fig. 10 U.S. pediatric diabetes management market, product outlook key takeaways (USD Million)
  • Fig. 11 U.S. pediatric diabetes management market product movement analysis 2024 & 2033 (USD Million)
  • Fig. 12 Blood glucose monitors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Continuous glucose monitors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Insulin pumps market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Insulin pens market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Insulin syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. pediatric diabetes management market, technology outlook key takeaways (USD Million)
  • Fig. 18 U.S. pediatric diabetes management market technology movement analysis 2024 & 2033 (USD Million)
  • Fig. 19 Connected devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Non-connected devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. pediatric diabetes management market, End Use outlook key takeaways (USD Million)
  • Fig. 22 U.S. pediatric diabetes management market End Use movement analysis 2024 & 2033 (USD Million)
  • Fig. 23 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 General hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Children hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Homecare market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Pediatric clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Heat map analysis
  • Fig. 29 Market participant categorization
  • Fig. 30 U.S. pediatric diabetes management market share analysis, 2024
  • Fig. 31 Strategy framework